Antiplatelet therapy increases symptomatic ICH risk after thrombolysis and thrombectomy. Couture M, Marnat G, Griffier R, Gariel F, et al. Acta Neurol Scand 2021;144:500-508.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Couture M, Marnat G, Griffier R, Gariel F, et al. Antiplatelet therapy increases symptomatic ICH risk after thrombolysis and thrombectomy. Acta Neurol Scand 2021;144:500-508.
PMID: 34042170